Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas
Clinical trial NCT02740270 · COMPLETED
Trial details
- NCT number
- NCT02740270
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-22
- Primary completion
- 2020-03-03
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.